Pages

Thursday, September 17, 2020

An ageing, less resilient immune response may facilitate more severe COVID-19 disease outcomes



Highlights
  • Adaptive immune responses limit COVID-19 disease severity
  • Multiple coordinated arms of adaptive immunity control better than partial responses
  • CXCL10 may be a biomarker of impaired T cell responses in acute COVID-19
  • Aging and scarcity of naive T cells may be linked risk factors for severe COVID-19

Summary
Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4+ and CD8+ T cell and neutralizing antibody responses in acute and convalescent subjects. SARS-CoV-2-specific CD4+ and CD8+ T cells were each associated with milder disease. Coordinated SARS-CoV-2-specific adaptive immune responses were associated with milder disease, suggesting roles for both CD4+ and CD8+ T cells in protective immunity in COVID-19. Notably, coordination of SARS-CoV-2 antigen-specific responses was disrupted in individuals > 65 years old. Scarcity of naive T cells was also associated with ageing and poor disease outcomes. A parsimonious explanation is that coordinated CD4+ T cell, CD8+ T cell, and antibody responses are protective, but uncoordinated responses frequently fail to control disease, with a connection between ageing and impaired adaptive immune responses to SARS-CoV-2.
Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity
Carolyn Rydyznski Moderbacher  Sydney I. Ramirez  Jennifer M. Dan  Davey M. Smith
Alessandro Sette Shane Crotty

Open AccessPublished:September 16, 2020DOI:https://doi.org/10.1016/j.cell.2020.09.038


No comments:

Post a Comment